回复@吃土喝茶: 3.29标本检测出结果吗？//@吃土喝茶:回复@吃土喝茶:NCT05496231
Sponsor:GlaxoSmithKline
Brief Summary:The Main purpose of this study is to evaluate the safety and reactogenicity of GlaxoSmithKline Biologicals SA (GSK)'s investigational adjuvanted human papillomavirus (HPV) vaccine formulations.
Official Title:A Phase 1/2 Randomized, Observer-blinded, Multi-country Study to Evaluate Safety and Immunogenicity of Investigational Adjuvanted Human Papillomavirus Vaccine in Females (16 to 26 Years of Age)
Phase 2
Enrollment (Estimated) :1080
网页链接